Text or call a human:Text (808) 600-9260Call
CorporateVentureCapital.com

Shionogi CVC

Profile, fund size and leaders

Parent ShionogiHQ Osaka, JapanFounded 2025

Shionogi CVC is the corporate venture arm of Shionogi, a pharmaceutical and biotech company. It was founded in 2025 and is based in Osaka, Japan. It invests from pre-seed to Series B. Sectors it names: biotech and life sciences, healthcare and digital health.

Commitment by parentS1
USD 14M

Every figure links to its source

Snapshot

Investment stage: Pre-seed to Series B
Data behind this graphic
Data behind this graphic
ItemValue
Stage rangePre-seed to Series B
SectorsBiotech and life sciences, Healthcare and digital health
GeographyNorth America, Europe, Asia
OfficesOsaka, Japan

Sources: S1 Shionogi: Corporate Venture Capital (CVC) page.

Graphic 1 of 2

Investment stage: Pre-seed to Series B

Sources: S1 Shionogi: Corporate Venture Capital (CVC) page.

Download:Report a correction
Scale and capital allocated
Data behind this graphic
Data behind this graphic
MeasureValueUnitKindSource
Headline sizeUSD 14MCommitment by parentStated by the firm or its parentS1

Sources: S1 Shionogi: Corporate Venture Capital (CVC) page.

Graphic 2 of 2

Scale and capital allocated

Firms and databases count companies, rounds and investments differently.

Sources: S1 Shionogi: Corporate Venture Capital (CVC) page.

Download:Report a correction

Where it invests and who leads it

Geography

Headquarters
Osaka, Japan

Investment regionsS1

LeadersS1

Shionogi CVC on LinkedIn

Key facts

FactValueStatusSource
Parent companyShionogiSingle sourceS1
Parent industryPharmaceuticals and biotechSingle sourceS1
Founded2025Single sourceS1
HeadquartersOsaka, JapanSingle sourceS2
StatusActiveSingle sourceS1
Capital sourceParent company onlySingle sourceS1
Headline sizeUSD 14M (Commitment by parent)Single sourceS1
People on the team page7Single sourceS1
StagesPre-seed, Seed, Series A, Series BSingle sourceS1

For founders

ItemWhat the firm saysSource
StagesPre-seed, Seed, Series A, Series BS1
Beyond capitalSupport from Shionogi research and development capabilities, business experience and networkS2
Pitch pagewww.shionogi.com/global/en/innovation/cvc.htmlS1

Fund vehicles

VehicleSizeYearSource
Shionogi CVC annual investment budgetUSD 14M2025S1

History

  1. Shionogi established its Corporate Venture Capital group in April 2025S2
  2. First CVC investment, in Restore Vision, announced 15 April 2026S2
  3. Investment in Dioseve announced 12 June 2026S3

Portfolio

Portfolio companies named in public sources: Restore Vision, Dioseve.S1

Shared portfolio with other corporate VCs

1 companies on the Shionogi CVC portfolio page also appear on the portfolio page of at least one other firm in this directory. Matched by company website, or by name where no website is published.

FirmSharedCompanies in common
Ajinomoto Group Ventures1Restore Vision
Astellas Venture Management1Restore Vision

Companies backed by the most corporate VCs

Official pages

Read the firm's own pages for current information.

  • Website www.shionogi.com/global/en/innovation/cvc.html

Sources

  1. S1Shionogi: Corporate Venture Capital (CVC) pageFirm
  2. S2Shionogi news: Investment in Restore Vision through its CVC activities (2026-04-15)Firm
  3. S3Shionogi news: Investment in Dioseve through its CVC activities (2026-06-12)Firm

Disclaimer and corrections

Not affiliated. This page is not affiliated with, endorsed by or sponsored by Shionogi CVC or any company named on it. Names and trademarks belong to their owners. Informational only. This is a public-source reference. It is not investment, legal or tax advice and not an offer or solicitation. Sources. Each figure names its source. Figures may have changed. Please read the firm's official pages, linked above. Corrections and takedown. To report an error or ask for a change or removal, use the correction form or email Richard@CorporateVentureCapital.com.

Spotted a mistake? Report a correction.